HCWB HCW Biologics Inc
Company Analysis
Latest News
🟢 HCW Biologics is trading 9.6% up today, extending a multi-day rally following a $1.6 million private placement
HCW Biologics is trading at $3.51 (9.6%) up today, extending a strong multi-day move that began late last week following a $1.6 million private placement. -...
🟢 HCW Biologics is trading 6.3% up today as it extends a rally following a $1.6 million private placement
HCW Biologics is trading at $3.40 (+6.25%) after extending a sharp two-day rally tied to its $1.6 million private placement. • The stock's upward momentum...
🟢 HCW Biologics is trading 5.1% up today, extending a rally following its $1.6 million private placement
HCW Biologics is trading 5.1% up at $3.31, extending a sharp two-day surge that began after the company priced a $1.6 million private placement at $2.585 per...
🔴 HCW Biologics is trading 7.6% down today as it pulls back from a private placement-driven surge
HCW Biologics is trading at $2.91, down 7.6% in after-hours as the stock pulls back from a sharp 22.09% regular-session jump. • The rally followed a recently...
🟢 HCW Biologics soars 14.3% today after private placement announced yesterday
HCW Biologics Inc. announced a $1.6 million private placement offering on Wednesday, July 29, 2026, with units priced at $2.585. • Shares reacted to the...
HCWB Bounces Back After $1.6 Million Stock Sale — But Can a Cash-Strapped Biotech Keep Diluting Its Way to Survival?
Shares of HCW Biologics shifted sharply this week, dropping 10.9% on Tuesday after the company announced a $1.6 million private placement — selling new stock...
🟢 HCW Biologics is trading 7.7% up today after announcing a $1.6M private placement
HCW Biologics is trading at $2.78 (7.7% up) today. • This follows the company's announcement of a $1.6 million private placement on July 29, 2026, which...
🔴 HCW Biologics is trading 10.9% down today after announcing a $1.6 million private placement
HCW Biologics is trading 10.9% down today at $2.30 following the announcement of a $1.6 million private placement of stock and warrants with accredited...
HCW Biologics to Raise $1.6M in a Private Placement of Stock and Warrants
HCW Biologics entered into a securities purchase agreement with accredited investors for a private placement expected to generate approximately $1.6 million in...
HCW Biologics Prices $1.6 Million Private Placement with Insider Participation
HCW Biologics Inc. priced a $1.6 million private placement. The placement includes company executives, directors, and an existing stockholder among its...
🟢 HCW Biologics is trading 6.8% up today on rebound from recent volatility
HCW Biologics is trading 6.8% up at $2.76 as the stock bounces back from several sharp moves over the past week. • The move appears driven by thin trading and...
🟢 HCW Biologics is trading 7.5% up today as it rebounds from recent volatility on light news flow
HCW Biologics is trading at $2.78 (7.5%) up today, rebounding modestly from recent volatility and sharp declines seen last week. • There are no fresh...
🟢 HCW Biologics is trading 6.8% up today as shares rebound on FDA meeting request interest
HCW Biologics is trading at $2.67 (6.8% up) as shares recover from last week’s steep decline, bolstered by renewed investor focus on its regulatory...
HCW Biologics Bounces 11% on FDA Meeting Request — But Can a Preclinical Cancer Drug Prop Up a $6 Million Company?
Shares of HCW Biologics shifted sharply higher in pre-market trading Monday, rebounding 11.2% to $2.78 after a bruising five-session slide that cut the stock...
🟢 HCW Biologics is trading 11.2% up today as it rebounds from a sharp selloff following an FDA meeting request update
HCW Biologics is trading at $2.78 (11.2%) up today, rebounding after a sharp multi-day selloff that saw the price drop from above $4 to $2.50. • The move...
🟢 HCW Biologics is trading 6.4% up today as it bounces from a sharp multi-day selloff
HCW Biologics is trading at $2.66 (6.4% up) in pre-market, bouncing after a steep multi-day selloff from above $4 to $2.50. • The move follows recent...
🔴 HCW Biologics is trading 6% down today following recent FDA meeting request
• HCW Biologics is trading 6% down at $2.35 in after-hours trading, extending a sharp multi-day slide. • The move follows the company's announcement yesterday,...
🟢 HCW Biologics is trading 7.2% up today in a technical after-hours bounce
HCW Biologics is trading 7.2% up at $2.68 in after-hours action, staging a technical rebound after a sharp multi-day slide despite no new company-specific...
🔴 HCW Biologics is trading 11.1% down today, extending a steep multi-day slide
HCW Biologics is trading 11.1% down at $2.56, extending a steep multi-day slide amid continued downside momentum and profit-taking. • The stock has seen a...
🔴 HCW Biologics is trading 6.3% down today, extending a week of sharp declines
HCW Biologics is trading 6.3% down at $2.70 today, continuing a period of significant weakness despite a lack of new fundamental catalysts. • The stock has...